keyword
Keywords Evaluation of no evidence of d...

Evaluation of no evidence of disease activity in a 7 year

https://read.qxmd.com/read/37643509/neuron-derived-extracellular-vesicles-to-examine-brain-mtor-target-engagement-with-sirolimus-in-patients-with-multiple-system-atrophy
#41
JOURNAL ARTICLE
Krishna A Pucha, Thong C Ma, William York, Un Jung Kang, Horacio Kaufmann, Dimitrios Kapogiannis, Jose-Alberto Palma
INTRODUCTION: Impaired autophagy is a pathogenic mechanism in the synucleinopathies. Sirolimus, a potent mTOR inhibitor and autophagy activator, had no beneficial effects in a randomized placebo-controlled trial in patients with multiple system atrophy (MSA). Whether sirolimus effectively inhibited brain mTOR activity was unknown. We aimed to evaluate if patients with MSA treated with sirolimus had evidence of inhibited brain mTOR pathways by measuring neuron-derived serum extracellular vesicles (NEVs)...
October 2023: Parkinsonism & related Disorders
https://read.qxmd.com/read/37585372/favorable-experience-of-transplant-strategy-including-liver-grafts-from-covid-19-donors-one-year-follow-up-results
#42
JOURNAL ARTICLE
Silvia Martini, Margherita Saracco, Donatella Cocchis, Fabrizia Pittaluga, Bruna Lavezzo, Francesca Barisone, Luigi Chiusa, Antonio Amoroso, Massimo Cardillo, Paolo A Grossi, Renato Romagnoli
BACKGROUND: Since November 2020, Italy was the first country to carry out a protocol and use liver from COVID-19 donors. We aimed to evaluate the medium-term outcome of patients who underwent liver transplant (LT) with those grafts. METHODS: We consecutively enrolled 283 patients who underwent first LT from November 2020 to December 2022 in our Center (follow-up 468 days). Twenty-five of 283 (8.8%, study population) received a graft from donors with previous (4%) or active (96%) SARS-CoV-2 infection, and 258/283 (91...
August 16, 2023: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://read.qxmd.com/read/37543519/relationship-between-lifestyle-habits-and-cardiovascular-risk-factors-in-familial-hypercholesterolemia
#43
JOURNAL ARTICLE
Laurie Dessureault, Gabrielle Roy, Patrick Couture, Anne Gangloff, Marta Guasch-Ferré, Louis Pérusse, Angelo Tremblay, Jean-Philippe Drouin-Chartier
BACKGROUND AND AIM: Little is known about the cardioprotective potential of a healthy lifestyle in familial hypercholesterolemia (FH). The objective of this study was to evaluate the relationship between lifestyle and cardiovascular risk factors in adults with FH. METHODS AND RESULTS: This cross-sectional study leveraged data from the CARTaGENE Quebec population-based cohort (Canada). Participants with FH were identified using the validated Simplified Canadian Definition for FH...
June 23, 2023: Nutrition, Metabolism, and Cardiovascular Diseases: NMCD
https://read.qxmd.com/read/37538264/omega-3-intake-is-associated-with-liver-disease-protection
#44
JOURNAL ARTICLE
Mara Sophie Vell, Kate Townsend Creasy, Eleonora Scorletti, Katharina Sophie Seeling, Leonida Hehl, Miriam Daphne Rendel, Kai Markus Schneider, Carolin Victoria Schneider
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease are among the most common liver diseases worldwide, and there are currently no Food and Drug Administration (FDA)-approved treatments. Recent studies have focused on lifestyle changes to prevent and treat NAFLD. Omega-3 supplementation is associated with improved outcomes in patients with chronic liver disease. However, it is unclear whether Omega-3 supplementation can prevent the development of liver disease, particularly in individuals at an increased (genetic) risk...
2023: Frontiers in Public Health
https://read.qxmd.com/read/37522826/-systemic-inflammatory-response-in-cardiac-surgery-possibilities-of-using-colchicine
#45
JOURNAL ARTICLE
M L Diakova, V M Shipulin, Y S Svirko, A M Gusakova, Y K Podoksenov, N O Kamenshchikov, B N Kozlov
AIM: To evaluate manifestations of systemic inflammatory response (SIR) and the effect of the colchicine therapy on SIR severity in patients with ischemic heart disease (IHD) after coronary artery bypass grafting (CABG) with extracorporeal circulation (EC). MATERIAL AND METHODS: This study included 100 patients aged 62+6.3 years with stable IHD and multivessel coronary atherosclerosis scheduled for CABG with EC. Patients of group 1 (n=50) were administered with a single dose of colchicine (Colchicum-Dispert) 500 µg 4 hours before surgery followed by 500 µg twice a day for 10 days after surgery...
July 28, 2023: Kardiologiia
https://read.qxmd.com/read/37483622/dimethyl-fumarate-related-immune-and-transcriptional-signature-is-associated-with-clinical-response-in-multiple-sclerosis-treated-patients
#46
JOURNAL ARTICLE
Alicia Sánchez-Sanz, Santiago García-Martín, Julia Sabín-Muñoz, Irene Moreno-Torres, Víctor Elvira, Fátima Al-Shahrour, Aranzazu García-Grande, Elvira Ramil, Ofir Rodríguez-De la Fuente, Beatriz Brea-Álvarez, Ruth García-Hernández, Antonio García-Merino, Antonio José Sánchez-López
BACKGROUND AND OBJECTIVE: Dimethyl fumarate (DMF) is an immunomodulatory drug approved for the therapy of multiple sclerosis (MS). The identification of response biomarkers to DMF is a necessity in the clinical practice. With this aim, we studied the immunophenotypic and transcriptomic changes produced by DMF in peripheral blood mononuclear cells (PBMCs) and its association with clinical response. MATERIAL AND METHODS: PBMCs were obtained from 22 RRMS patients at baseline and 12 months of DMF treatment...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37436070/systemic-pharmacological-treatments-for-chronic-plaque-psoriasis-a-network-meta-analysis
#47
REVIEW
Emilie Sbidian, Anna Chaimani, Robin Guelimi, Ignacio Garcia-Doval, Camille Hua, Carolyn Hughes, Luigi Naldi, Maria Kinberger, Sivem Afach, Laurence Le Cleach
BACKGROUND: Psoriasis is an immune-mediated disease with either skin or joints manifestations, or both, and it has a major impact on quality of life. Although there is currently no cure for psoriasis, various treatment strategies allow sustained control of disease signs and symptoms. The relative benefit of these treatments remains unclear due to the limited number of trials comparing them directly head-to-head, which is why we chose to conduct a network meta-analysis. OBJECTIVES: To compare the benefits and harms of non-biological systemic agents, small molecules, and biologics for people with moderate-to-severe psoriasis using a network meta-analysis, and to provide a ranking of these treatments according to their benefits and harms...
July 12, 2023: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/37429302/pembrolizumab-in-patients-with-rare-and-ultra-rare-sarcomas-acs%C3%A3-pembrolizumab-analysis-of-a-subgroup-from-a-non-randomised-open-label-phase-2-basket-trial
#48
JOURNAL ARTICLE
Jean-Yves Blay, Sylvie Chevret, Axel Le Cesne, Mehdi Brahmi, Nicolas Penel, Sophie Cousin, Francois Bertucci, Emmanuelle Bompas, Thomas Ryckewaert, Pauline Soibinet, Pascaline Boudou-Rouquette, Esma Saada Bouzid, Patrick Soulie, Thibaud Valentin, Jean-Pierre Lotz, Diego Tosi, Zoé Neviere, Mathilde Cancel, Isabelle Ray-Coquard, Laetitia Gambotti, Frédéric Legrand, Assia Lamrani-Ghaouti, Clotilde Simon, Caroline Even, Christophe Massard
BACKGROUND: Sarcoma is a heterogeneous group of diseases with few treatment options. Immunotherapy has shown little activity in studies including unselected sarcomas, but immune checkpoint blockers have shown activity in specific histotypes. We evaluated the activity of pembrolizumab in rare and ultra-rare sarcomas. METHODS: AcSé Pembrolizumab is an ongoing phase 2, basket, multitumour study investigating the activity of pembrolizumab monotherapy in rare cancers...
August 2023: Lancet Oncology
https://read.qxmd.com/read/37390044/effect-of-bariatric-surgery-on-disease-outcomes-in-patients-with-inflammatory-bowel-disease-a-us-based-propensity-matched-cohort-study
#49
JOURNAL ARTICLE
Aakash Desai, Jana G Hashash, Gianna Baker, Francis A Farraye, Nisheet Waghray, Gursimran S Kochhar
INTRODUCTION AND AIM: A growing body of evidence suggests a negative impact of obesity on the disease activity of inflammatory bowel disease (IBD). The primary aim of the study was to evaluate disease outcomes of IBD in patients after bariatric surgery (BS). METHODS: Patients with IBD and morbid obesity who underwent BS were compared with patients with IBD and morbid obesity without BS in a retrospective, propensity-score matched cohort study using TriNetX, a multi-institutional database...
June 27, 2023: Journal of Clinical Gastroenterology
https://read.qxmd.com/read/37384135/the-physical-activity-at-work-paw-study-a-cluster-randomised-trial-of-a-multicomponent-short-break-intervention-to-reduce-sitting-time-and-increase-physical-activity-among-office-workers-in-thailand
#50
JOURNAL ARTICLE
Katika Akksilp, Jemima Jia En Koh, Vanessa Tan, Eunice Huiying Tong, Nuttakarn Budtarad, Guo Xueying, Anna Valeria Dieterich, Bee Choo Tai, Andre Matthias Müller, Wanrudee Isaranuwatchai, Thomas Rouyard, Ryota Nakamura, Falk Müller-Riemenschneider, Yot Teerawattananon, Cynthia Chen
BACKGROUND: Sedentary behaviour increases the risks of non-communicable diseases. The objective of this trial was to evaluate the effect of the Physical Activity at Work multicomponent intervention to reduce sedentary behaviour in Thai office workers. METHODS: Offices under the Ministry of Public Health Thailand, were randomly allocated to the intervention and control group in a 1:1 ratio, stratified by office size. The intervention included individual (pedometer and lottery-based financial incentives), social (group movement breaks), environmental (posters), and organisational (leader encouragement) components...
January 2023: Lancet Reg Health Southeast Asia
https://read.qxmd.com/read/37327598/knowledge-and-worries-on-motherhood-choice-in-multiple-sclerosis-a-cross-sectional-study-on-patient-reported-outcome-measures
#51
JOURNAL ARTICLE
Julia Peper, Sascha Köpke, Alessandra Solari, Andrea Giordano, Stefan M Gold, Kerstin Hellwig, Lea Steinberg, Anke Steckelberg, Christoph Heesen, Anne Christin Rahn
BACKGROUND: Since multiple sclerosis (MS) is often diagnosed in young women, pregnancy is a common topic for women with MS (wwMS). The study aimed to assess the measurement properties of two patient-reported outcome measures on motherhood choice in MS, and to explore the information and support needs of wwMS concerning motherhood. METHODS: We conducted an anonymous web-based survey to validate the motherhood/pregnancy choice and worries questionnaire (MPWQ, 31 items plus up to 3 additional items) and the motherhood choice knowledge questionnaire (MCKQ, 16 items)...
June 4, 2023: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/37321663/intratumoral-pan-erbb-targeted-car-t-for-head-and-neck-squamous-cell-carcinoma-interim-analysis-of-the-t4-immunotherapy-study
#52
JOURNAL ARTICLE
Sophie Papa, Antonella Adami, Michael Metoudi, Richard Beatson, Molly Sarah George, Daniela Achkova, Evangelia Williams, Sefina Arif, Fiona Reid, Maria Elstad, Nicholas Beckley-Hoelscher, Abdel Douri, Marc Delord, Mike Lyne, Dharshene Shivapatham, Christopher Fisher, Andrew Hope, Sakina Gooljar, Arindam Mitra, Linda Gomm, Cienne Morton, Rhonda Henley-Smith, Selvam Thavaraj, Alice Santambrogio, Cynthia Andoniadou, Sarah Allen, Victoria Gibson, Gary J R Cook, Ana C Parente-Pereira, David M Davies, Farzin Farzaneh, Anna Schurich, Teresa Guerrero-Urbano, Jean-Pierre Jeannon, James Spicer, John Maher
BACKGROUND: Locally advanced/recurrent head and neck squamous cell carcinoma (HNSCC) is associated with significant morbidity and mortality. To target upregulated ErbB dimer expression in this cancer, we developed an autologous CD28-based chimeric antigen receptor T-cell (CAR-T) approach named T4 immunotherapy. Patient-derived T-cells are engineered by retroviral transduction to coexpress a panErbB-specific CAR called T1E28ζ and an IL-4-responsive chimeric cytokine receptor, 4αβ, which allows IL-4-mediated enrichment of transduced cells during manufacture...
June 2023: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/37315892/successful-hysteroscopic-management-of-cesarean-scar-defect-pregnancy
#53
JOURNAL ARTICLE
Sebastián Lavanderos, Heinz Dauelsberg, Fernanda Muñoz, Camila Muñoz, Gabriela Rodríguez, José Lira
No abstract text is available yet for this article.
June 12, 2023: Journal of Minimally Invasive Gynecology
https://read.qxmd.com/read/37303752/effectiveness-of-tumor-necrosis-factor-inhibitors-in-children-with-enthesitis-related-arthritis-a-single-center-retrospective-analysis
#54
JOURNAL ARTICLE
Tonghao Zhang, Shuoyin Huang, Yanli Guo, Jing Jin, Wu Yan, Panpan Wang, Yuying Fang, Yingying Liu, Yuting Pan, Zhidan Fan, Haiguo Yu
OBJECTIVE: In children with enthesitis-related arthritis (ERA), the hip and sacroiliac joint function might be impaired if not properly treated. We sought to evaluate the effectiveness of anti-tumor necrosis factor-α (TNF-α) therapy using the inflammatory indicators, Juvenile Arthritis Disease Activity Score 27 (JADAS27) and magnetic resonance imaging (MRI). METHODS: We conducted a single-center retrospective study of 134 patients with ERA. We evaluated the effect of anti-TNF therapy on the inflammatory indicators, active joint count, MRI quantitative score, and JADAS27 over 18 months...
2023: Frontiers in Pediatrics
https://read.qxmd.com/read/37238250/liver-involvement-in-patients-with-systemic-sclerosis-role-of-transient-elastography-in-the-assessment-of-hepatic-fibrosis-and-steatosis
#55
JOURNAL ARTICLE
Giovanna Cuomo, Carlo Iandoli, Raffaele Galiero, Alfredo Caturano, Claudio Di Vico, Danilo Perretta, Pier Vincenzo Adamo, Roberta Ferrara, Luca Rinaldi, Ciro Romano, Ferdinando Carlo Sasso
Background Systemic sclerosis (SSc) is a rare, multisystemic disorder of connective tissue characterized by widespread inflammation, vascular abnormalities, and both skin and visceral organ fibrosis. Tissue fibrosis is the final phase of a complex biological process of immune activation and vascular damage. Objectives The aim of the study was to assess hepatic fibrosis and steatosis in SSc patients by transient elastography (TE). Methods Fifty-nine SSc patients fulfilling the 2013 ACR/EULAR classification criteria were recruited...
May 17, 2023: Diagnostics
https://read.qxmd.com/read/37237267/fatigue-depression-and-product-tolerability-during-long-term-treatment-with-intravenous-immunoglobulin-gamunex%C3%A2-10-in-patients-with-chronic-inflammatory-demyelinating-polyneuropathy
#56
JOURNAL ARTICLE
Juliane Klehmet, Björn Tackenberg, Judith Haas, Bernd C Kieseier
INTRODUCTION/AIMS: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is characterized by progressive weakness and sensory loss, often affecting patient's ability to walk and perform activities of daily living independently. Furthermore, patients often report fatigue and depression which can affect their quality of life. These symptoms were assessed in CIDP patients receiving long-term intravenous immunoglobulin (IVIG) treatment. METHODS: GAMEDIS was a multi-center, prospective, non-interventional study in adult CIDP patients treated with IVIG (10%) and followed for two years...
May 26, 2023: BMC Neurology
https://read.qxmd.com/read/37235796/erratum-eyestalk-ablation-to-increase-ovarian-maturation-in-mud-crabs
#57
JOURNAL ARTICLE
(no author information available yet)
An erratum was issued for: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs. The Introduction, Protocol, Discussion and References were updated. The forth sentence in the third paragraph of the Introduction has been updated from: The eyestalk ablation protocol in this work minimizes stress by using fully sedated crabs and minimizes physical injury to personnel from crab bites.  to: The eyestalk ablation protocol in this work minimizes stress by using fully anesthetized crabs and minimizes physical injury to personnel from crab bites...
May 26, 2023: Journal of Visualized Experiments: JoVE
https://read.qxmd.com/read/37235039/lifestyle-interventions-kidney-disease-progression-and-quality-of-life-a-systematic-review-and-meta-analysis
#58
JOURNAL ARTICLE
Elizabeth P Neale, Vinicius Do Rosario, Yasmine Probst, Eleanor Beck, Thai Binh Tran, Kelly Lambert
RATIONALE & OBJECTIVE: Poor dietary patterns and low physical activity levels are important lifestyle-related factors that contribute to negative health outcomes in individuals with chronic kidney disease (CKD). Previous systematic reviews have not explicitly focused on these lifestyle factors, nor undertaken meta-analyses of any effects. We aimed to evaluate the effect of lifestyle interventions (such as diet, exercise, and other lifestyle-related interventions) on the risk factors for and progression of CKD and the quality of life...
June 2023: Kidney medicine
https://read.qxmd.com/read/37226563/cost-effectiveness-of-age-expanding-strategy-of-latent-tuberculosis-infection-treatment-in-household-contacts-in-south-korea
#59
JOURNAL ARTICLE
Hyunwoo Cho, Jeongjoo Seok, Youngmok Park, Hee Jin Kim, Eun Hye Lee, Jungeun Park, Dong Ah Park, Young Ae Kang, Jeehyun Lee
PURPOSE: The strategy of latent tuberculosis infection (LTBI) treatment in household tuberculosis (TB) contacts has been expanding in South Korea. However, there is little evidence of the cost-effectiveness of LTBI treatment in patients over 35 years of age. This study aimed to evaluate the cost-effectiveness of LTBI treatment among household TB contacts in different age groups in South Korea. MATERIALS AND METHODS: An age-structured model of TB was developed based on the reports from the Korea Disease Control and Prevention Agency and the National Health Insurance Service...
June 2023: Yonsei Medical Journal
https://read.qxmd.com/read/37182801/a-multicenter-open-label-randomized-phase-ii-study-of-cediranib-with-or-without-lenalidomide-in-iodine-131-refractory-differentiated-thyroid-cancer
#60
RANDOMIZED CONTROLLED TRIAL
A J Rosenberg, C-Y Liao, T Karrison, J A de Souza, F P Worden, B Libao, M K Krzyzanowska, D N Hayes, E Winquist, V Saloura, K Prescott, V M Villaflor, T Y Seiwert, R B Schechter, W M Stadler, E E W Cohen, E E Vokes
BACKGROUND: Multitargeted tyrosine kinase inhibitors (TKIs) of the vascular endothelial growth factor receptor (VEGFR) pathway have activity in differentiated thyroid cancer (DTC). Lenalidomide demonstrated preliminary efficacy in DTC, but its safety and efficacy in combination with VEGFR-targeted TKIs is unknown. We sought to determine the safety and efficacy of cediranib, a VEGFR-targeted TKI, with or without lenalidomide, in the treatment of iodine 131-refractory DTC. PATIENTS AND METHODS: In this multicenter, open-label, randomized, phase II clinical trial, 110 patients were enrolled and randomized to cediranib alone or cediranib with lenalidomide...
August 2023: Annals of Oncology: Official Journal of the European Society for Medical Oncology
keyword
keyword
59433
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.